Search Results - "Lackey, Philip C"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes by Hsu, Ricky K, Fusco, Jennifer S, Henegar, Cassidy E, Vannappagari, Vani, Clark, Andrew, Brunet, Laurence, Lackey, Philip C, Pierone, Jr, Gerald, Fusco, Gregory P

    Published in BMC infectious diseases (13-02-2023)
    “…Multi-class resistance, intolerance, and drug-drug interactions can result in unique antiretroviral (ART) combinations for heavily treatment-experienced (HTE)…”
    Get full text
    Journal Article
  2. 2

    Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study by Mills, Anthony M., Brunet, Laurence, Fusco, Jennifer S., Wohlfeiler, Michael B., Garris, Cindy P., Oglesby, Alan K., Mrus, Joseph M., Lackey, Philip C., Fusco, Gregory P.

    Published in Infectious diseases and therapy (01-03-2020)
    “…Introduction Dolutegravir (DTG), Elvitegravir (EVG), Raltegravir (RAL) and Darunavir (DRV) are commonly prescribed core agents for antiretroviral therapy…”
    Get full text
    Journal Article
  3. 3

    Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study by Hsu, Ricky K, Brunet, Laurence, Lackey, Philip C, Pierone, Jr, Gerald, Levis, Brooke, Fusco, Jennifer S, Henegar, Cassidy, Vannappagari, Vani, Clark, Andrew, Fusco, Gregory P

    Published in HIV medicine (25-08-2024)
    “…Fostemsavir is a novel attachment inhibitor used with other antiretrovirals in heavily treatment-experienced (HTE) adults with multidrug-resistant HIV-1…”
    Get full text
    Journal Article
  4. 4

    Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents by Mills, Anthony M, Schulman, Kathy L, Fusco, Jennifer S, Wohlfeiler, Michael B, Priest, Julie L, Oglesby, Alan, Brunet, Laurence, Lackey, Philip C, Fusco, Gregory P

    Published in Open forum infectious diseases (01-08-2021)
    “…Abstract Background People living with human immunodeficiency virus (PLWH) initiating antiretroviral therapy (ART) with viral loads (VLs) ≥100 000 copies/mL…”
    Get full text
    Journal Article
  5. 5